Predilytics, a Massachusetts-based health IT company that specializes in healthcare analytics and machine learning for health plans and providers, is in the midst of raising $10 million through the sale of equity, according to a filing with the SEC.
The company, founded in 2011, has raised about $8.9 million so far, with another $1 million remaining, according to the Form D.
Headed by CEO Chris Coloian, the company’s investors include Google Ventures, Foundation Medical Partners, Flybridge Capital Partners and Highland Capital Partners, according to its website.
The company says it provides “patented, machine-learning analytic tools to transform our clients’ structured and unstructured data, along with external data sources, into actionable insights.”
